Bio/Pharma News

Apr 03, 2014
By Pharmaceutical Technology Editors
Evzio, the first naloxone treatment specifically designed to administered to opioid overdose patients by family members or caregivers, approved in 15 weeks.
Mar 27, 2014
By Pharmaceutical Technology Editors
Baxter announces plans to split into two independent companies by mid-2015.
Mar 24, 2014
FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.
Mar 05, 2014
By Pharmaceutical Technology Editors
FDA approves the extended-release Bydureon Pen for the treatment of type 2 diabetes.
Feb 26, 2014
FDA approves the orphan drug Myalept for the treatment of leptin deficiency.
Feb 26, 2014
By Pharmaceutical Technology Editors
Moody's Investor Service reports AbbVie, Amgen, and Roche are the most exposed to biosimilar competition.
Feb 25, 2014
Nuevolution enters a license agreement with a subsidiary of Merck for small molecule compounds.
Feb 19, 2014
EMD Serono assigns operational changes.
Feb 19, 2014
By Pharmaceutical Technology Editors
The combined company will create blockbuster product franchises in the central nervous system, gastroenterology, women's health, urology, and cardiovascular therapeutic categories.
Feb 18, 2014
DIR Technologies will work with Pfizer to perform a three-month trial of the company's packaging integrity testing systems.
native1_300x100
lorem ipsum